Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert J. Gould currently holds 469,864 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Gould has been a net seller of FULC stock. They have purchased $0 and sold $17.9M worth of shares.
Robert J. Gould's most recent insider trade was on Jan 2, 2026, when they sold 15,000 shares at $11.87 per share.
Robert J. Gould serves as Executive at Fulcrum Therapeutics, Inc. (FULC). They have executed 83 insider transactions totaling $17.9M over their tenure at the company.
Robert J. Gould holds the position of Executive at Fulcrum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Robert J. Gould has shown a selling trading pattern, with $0 in total purchases and $17.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert J. Gould was on Apr 5, 2022, when they sold $1.3M worth of FULC shares. This transaction involved 52,552 shares at $24.26 per share.
Robert J. Gould currently owns 469,864 shares of Fulcrum Therapeutics, Inc. (FULC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert J. Gould's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert J. Gould has 83 Form 4 filings on record as an insider at Fulcrum Therapeutics, Inc..
Set alerts for Robert J. Gould and 40,000+ other insiders.